본문 바로가기
KERD
논문KCI 등재

Obesity, Inflammation and Diet

1

조회

0

다운로드

7

인용

0

참고문헌

키워드

주제분류소아과학

초록

Obesity is a state in which there is an over-accumulation of subcutaneous and/or abdominal adipose tissue. This adipose tissue is no longer considered inert and mainly devoted to storing energy; it is emerging as an active tissue in the regulation of physiological and pathological processes, including immunity and inflammation. Adipose tissue produces and releases a variety of adipokines (leptin, adiponectin, resistin, and visfatin), as well as pro- and anti-in-flammatory cytokines (tumor necrosis factor-α, interleukin [IL]-4, IL-6, and others). Adipose tissue is also implicated in the development of chronic metabolic diseases such as type 2 diabetes mellitus or cardiovascular disease. Obesity is thus an underlying condition for inflammatory and metabolic diseases. Diet or dietary patterns play critical roles in obesity and other pathophysiological conditions. A healthy diet and some nutrients are generally considered benefi-cial; however, some dietary nutrients are still considered controversial. In this article, dietary factors that influence inflammation associated with obesity are discussed. (Pediatr Gastroenterol Hepatol Nutr 2013; 16: 143∼152)

Abstract

Obesity is a state in which there is an over-accumulation of subcutaneous and/or abdominal adipose tissue. This adipose tissue is no longer considered inert and mainly devoted to storing energy; it is emerging as an active tissue in the regulation of physiological and pathological processes, including immunity and inflammation. Adipose tissue produces and releases a variety of adipokines (leptin, adiponectin, resistin, and visfatin), as well as pro- and anti-in-flammatory cytokines (tumor necrosis factor-α, interleukin [IL]-4, IL-6, and others). Adipose tissue is also implicated in the development of chronic metabolic diseases such as type 2 diabetes mellitus or cardiovascular disease. Obesity is thus an underlying condition for inflammatory and metabolic diseases. Diet or dietary patterns play critical roles in obesity and other pathophysiological conditions. A healthy diet and some nutrients are generally considered benefi-cial; however, some dietary nutrients are still considered controversial. In this article, dietary factors that influence inflammation associated with obesity are discussed. (Pediatr Gastroenterol Hepatol Nutr 2013; 16: 143∼152)

참고문헌 (77)

  1. Finkelstein EA, "Annual medical spending attributable to obesity: payer- and service-specific estimates", Health Aff (Millwood), 28, pp.w822~831 (2009)
  2. "Obesity"[URL]
  3. "Estimated future population 2010-2060"[URL]
  4. "The Korean National Health and Nutrition Examination Survey (KNHANES)"[URL]
  5. Trayhurn P, "Adipokines: inflammation andthe pleiotropic role of white adipose tissue", Br J Nutr, 92, pp.347~355 (2004)
  6. Galic S, "Adipose tissue as an endocrine organ", Mol Cell Endocrinol, 316, pp.129~139 (2010)
  7. Hajer GR, "Adipose tissue dysfunction in obesity, diabetes, and vascular diseases", Eur Heart J, 29, pp.2959~2971 (2008)
  8. Galland L, "Diet and inflammation", Nutr Clin Pract, 25, pp.634~640 (2010)
  9. Bulló M, "Inflammation, obesity and comorbidities: the role of diet", Public Health Nutr, 10, pp.1164~1172 (2007)
  10. Calder PC, "Dietary factors and low-grade inflammation in relation to overweight and obesity", Br J Nutr, 106(3), pp.S5~78 (2011)
  11. Calabro P, "Obesity, inflammation, and vascular disease: the role of the adipose tissue as an endocrine organ", Subcell Biochem, 42, pp.63~91 (2007)
  12. Tilg H, "Adipocytokines: mediators linking adipose tissue, inflammation and immunity", Nat Rev Immunol, 6, pp.772~783 (2006)
  13. Ceddia RB, "Analysis of paradoxical observations on the association between leptin and insulin resistance", FASEB J, 16, pp.1163~1176 (2002)
  14. Ekmekci H, "The role of adiponectin in atherosclerosis and thrombosis", Clin Appl Thromb Hemost, 12, pp.163~168 (2006)
  15. Fukuhara A, "Visfatin: a protein secreted by visceral fat that mimics the effects of insulin", Science, 307, pp.426~430 (2005)
  16. Steppan CM, "The hormone resistin links obesity to diabetes", Nature, 409, pp.307~312 (2001)
  17. Purohit A, "Aromatase activity and interleukin- 6 production by normal and malignant breast tissues", J Clin Endocrinol Metab, 80, pp.3052~3058 (1995)
  18. Koh KK, "Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions", J Am Coll Cardiol, 46, pp.1978~1985 (2005)
  19. Mandrup-Poulsen T, "The role of interleukin-1 in the pathogenesis of IDDM", Diabetologia, 39, pp.1005~1029 (1996)
  20. Horn F, "Interleukin-6 signal transduction and lymphocyte function", Immunobiology, 202, pp.151~167 (2000)
  21. Brown MA, "Functions of IL-4 and control of its expression", Crit Rev Immunol, 17, pp.1~32 (1997)
  22. Marchant A, "Interleukin-10 production during septicaemia", Lancet, 343, pp.707~708 (1994)
  23. Schroder K, "Interferon-gamma: an overview of signals, mechanisms and functions", J Leukoc Biol, 75, pp.163~189 (2004)
  24. Gregor MF, "Inflammatory mechanisms in obesity", Annu Rev Immunol, 29, pp.415~445 (2011)
  25. Hotamisligil GS, "Inflammation and metabolic disorders", Nature, 444, pp.860~867 (2006)
  26. Ron D, "Signal integration in the endoplasmic reticulum unfolded protein response", Nat Rev Mol Cell Biol, 8, pp.519~529 (2007)
  27. Urano F, "Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1", Science, 287, pp.664~666 (2000)
  28. Deng J, "Translational repression mediates activation of nuclear factor kappa B by phosphorylated translation initiation factor", Mol Cell Biol, 24, pp.10161~10168 (2004)
  29. Gregor MF, "Thematic review series: adipocyte biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease", J Lipid Res, 48, pp.1905~1914 (2007)
  30. Surmi BK, "Macrophage infiltration into adipose tissue: initiation, propagation and remodeling", Future Lipidol, 3, pp.545~556 (2008)
  31. Hosogai N, "Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation", Diabetes, 56, pp.901~911 (2007)
  32. Ye J, "Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob", ob and dietary obese mice, 2007, pp.293, E1118~1128
  33. Shi H, "TLR4 links innate immunity and fatty acid-induced insulin resistance", J Clin Invest, 116, pp.3015~3025 (2006)
  34. Jenkins DJ, "Glycemic index of foods: a physiological basis for carbohydrate exchange", Am J Clin Nutr, 34, pp.362~366 (1981)
  35. Salmerón J, "Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women", JAMA, 277, pp.472~477 (1997)
  36. Levitan EB, "Dietary glycemic index, dietary glycemic load, blood lipids, and C-reactiveprotein", Metabolism, 57, pp.437~443 (2008)
  37. Du H, "Glycemic index and glycemic load in relation to food and nutrient intake and metabolic risk factors in a Dutch population", Am J Clin Nutr, 87, pp.655~661 (2008)
  38. Qi L, "Dietary fibers and glycemic load, obesity, and plasma adiponectin levels in women with type 2 diabetes", Diabetes Care, 29, pp.1501~1505 (2006)
  39. Pischon T, "Association between dietary factors and plasma adiponectin concentrations in men", Am J Clin Nutr, 81, pp.780~786 (2005)
  40. Pittas AG, "The effects of the dietary glycemic load on type 2 diabetes risk factors during weight loss", Obesity, 14, pp.2200~2209 (2006)
  41. Shikany JM, "Effects of low- and high-glycemic index", glycemic load diets on coronary heart disease risk factors in overweight, Metabolism, pp.2009, 58[DOI]
  42. Vrolix R, "Effects of glycemic load on metabolic risk markers in subjects at increased risk of developing metabolic syndrome", Am J Clin Nutr, 92, pp.366~374 (2010)
  43. Joffe YT, "The relationship between dietary fatty acids and inflammatory genes on the obese phenotype and serum lipids", Nutrients, 5, pp.1672~1705 (2013)
  44. Lopez-Garcia E, "Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women", J Nutr, 134, pp.1806~1811 (2004)
  45. Zampelas A, "Fish consumption among healthy adults is associated with decreased levels of inflammatory markers related to cardiovascular disease: the ATTICA study", J Am Coll Cardiol, 46, pp.120~124 (2005)
  46. Ciubotaru I, "Dietary fish oil decreases C-reactive protein, interleukin-6, and triacylglycerol to HDL-cholesterol ratio in postmenopausal women on HRT", J Nutr Biochem, 14, pp.513~521 (2003)
  47. Lopez-Garcia E, "Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction", J Nutr, 135, pp.562~566 (2005)
  48. Baer DJ, "Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study", Am J Clin Nutr, 79, pp.969~973 (2004)
  49. Lichtenstein AH, "Influence of hydrogenated fat and butter on CVD risk factors: remnant-like particles, glucose and insulin, blood pressure and C-reactive protein", Atherosclerosis, 171, pp.97~107 (2003)
  50. Bhupathiraju SN, "Greater variety in fruit and vegetable intake is associated with lower inflammation in Puerto Rican adults", Am J Clin Nutr, 93, pp.37~46 (2011)
  51. Salas-Salvadó J, "Components of the Mediterranean-type food pattern and serum inflammatory markers among patients at high risk for cardiovascular disease", Eur J Clin Nutr, 62, pp.651~659 (2008)
  52. Freese R, "No difference in platelet activation or inflammation markers after diets rich or poor in vegetables, berries and apple in healthy subjects", Eur J Nutr, 43, pp.175~182 (2004)
  53. Morand C, "Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers", Am J Clin Nutr, 93, pp.73~80 (2011)
  54. Brady WE, "Human serum carotenoid concentrations are related to physiologic and lifestyle factors", J Nutr, 126, pp.129~137 (1996)
  55. Wang L, "Associations of plasma carotenoids with risk factors and biomarkers related to cardiovascular disease in middle-aged and older women", Am J Clin Nutr, pp.747~754 (2008)
  56. Aasheim ET, "Vitamin status in morbidly obese patients: a cross-sectional study", Am J Clin Nutr, 87, pp.362~369 (2008)
  57. Block G, "Plasma C-reactive protein concentrations in active and passive smokers: influence of antioxidant supplementation", J Am Coll Nutr, 23, pp.141~147 (2004)
  58. Fumeron C, "Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients", Nephrol Dial Transplant, 20, pp.1874~1879 (2005)
  59. Chacko SA, "Relations of dietary magnesium intake to biomarkers of inflammation and endothelialdysfunction in an ethnically diverse cohort of postmenopausal women", Diabetes Care, 33, pp.304~310 (2010)
  60. Guerrero-Romero F, "Relationship between serum magnesium levels and C-reactive protein concentration, in non-diabetic, non-hypertensive obese subjects", Int J Obes Relat Metab Disord, 26, pp.469~474 (2002)
  61. Landberg R, "Selected dietary flavonoids are associated with markers of inflammation and endothelial dysfunction in U.S. women", J Nutr, 141, pp.618~625 (2011)
  62. Chun OK, "Serum C-reactive protein concentrations are inversely associated with dietary flavonoid intake in U.S. adults", J Nutr, 138, pp.753~760 (2008)
  63. Karlsen A, "Anthocyanins inhibit nuclear factor- kappaB activation in monocytes and reduce plasma concentrations of pro-inflammatory mediators in healthy adults", J Nutr, 137, pp.1951~1954 (2007)
  64. Karlsen A, "Bilberry juice modulates plasma concentration of NF-kappaB related inflammatory markers in subjects at increased risk of CVD", Eur J Nutr, 49, pp.345~355 (2010)
  65. Suomela JP, "Absorption of flavonols derived from sea buckthorn (Hippophaë rhamnoides L.) and their effect on emerging risk factors for cardiovascular disease in humans", J Agric Food Chem, 54, pp.7364~7369 (2006)
  66. D'Anna R, "The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women", Acta Obstet Gynecol Scand, 84, pp.474~477 (2005)
  67. Yildiz MF, "Effects of raloxifene, hormone therapy, and soy isoflavone on serum high-sensitive C-reactive protein in postmenopausal women", Int J Gynaecol Obstet, 90, pp.128~133 (2005)
  68. Clerici C, "Pasta naturally enriched with isoflavone aglycons from soy germ reduces serum lipids and improves markers of cardiovascular risk", J Nutr, 137, pp.2270~2278 (2007)
  69. Aubertin-Leheudre M, "Effect of 6 months of exercise and isoflavone supplementation on clinical cardiovascular risk factors in obese postmenopausal women: a randomized, double- blind study", Menopause, 14, pp.624~629 (2007)
  70. Salminen S, "Functional food science and gastrointestinal physiology and function", Br J Nutr, 80(1), pp.S147~171 (1998)
  71. Nova E, "Immunomodulatory effects of probiotics in different stages of life", Br J Nutr, 98(1), pp.S90~95 (2007)
  72. Olivares M, "The consumption of two new probiotic strains, Lactobacillus gasseri CECT 5714 and Lactobacillus coryniformis CECT 5711, boosts the immune system of healthy humans", Int Microbiol, 9, pp.47~52 (2006)
  73. Olivares M, "Dietary deprivation of fermented foods causes a fall in innate immune response. Lactic acid bacteria can counteract the immunological effect of this deprivation", J Dairy Res, 73, pp.492~498 (2006)
  74. Kekkonen RA, "Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults", World J Gastroenterol, 14, pp.2029~2036 (2008)
  75. Pineiro M, "FAO technical meeting on prebiotics", J Clin Gastroenterol, 4(3), pp.S156~159 (2008)
  76. Guigoz Y, "Effects of oligosaccharide on the faecal flora and non-specific immune system in elderly people", Nutr Res, 22, pp.13~25 (2002)
  77. Schiffrin EJ, "Systemic inflammatory markers in older persons: the effect of oral nutritional supplementation with prebiotics", J Nutr Health Aging, 11, pp.475~479 (2007)

관련 논문AI추천

이 간행물의 다른 논문 (9건)